Compare FULT & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FULT | ITGR |
|---|---|---|
| Founded | 1882 | 1970 |
| Country | United States | United States |
| Employees | 3400 | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.0B |
| IPO Year | N/A | 2000 |
| Metric | FULT | ITGR |
|---|---|---|
| Price | $20.60 | $86.57 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 7 |
| Target Price | $21.40 | ★ $91.14 |
| AVG Volume (30 Days) | ★ 1.9M | 674.5K |
| Earning Date | 04-14-2026 | 04-23-2026 |
| Dividend Yield | ★ 3.74% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.89 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | $6.39 | $1.69 |
| Revenue Next Year | $5.52 | $6.53 |
| P/E Ratio | ★ $10.58 | $30.42 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $14.33 | $62.00 |
| 52 Week High | $22.99 | $127.56 |
| Indicator | FULT | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 55.38 | 55.09 |
| Support Level | $19.05 | $82.58 |
| Resistance Level | $21.01 | $88.36 |
| Average True Range (ATR) | 0.50 | 2.46 |
| MACD | 0.12 | 0.22 |
| Stochastic Oscillator | 92.11 | 72.18 |
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.